UK Approves Pfizer-Made Vaccine Regulations Starting December 1

Photo illustration (Daniel Schludi / Unsplash)

JAKARTA - The British government is scheduled to pass regulatory approval for the COVID-19 vaccine made by Pfizer in collaboration with BioNtech on 1 December. This was revealed by the British government because they had judged that the vaccine made by Pfizer was fit for distribution.

Launching CNA, Monday, November 23, the British side will start reviewing the latest data on a potential vaccine made by Pfizer. However, the UK Department of Health has yet to comment on when the first vaccinations will be given to citizens.

A UK government spokesman confirmed that the authorization process by the medical regulator the Medicines and Health Products Regulatory Agency (MHRA) is independent of the government. This is because it is the MHRA who will decide how long it will take to review the final data from Pfizer to immediately launch a vaccine to the public.

"A great deal of planning has been done to ensure our healthcare services are ready to launch a COVID-19 vaccine," the spokesman added.

Earlier, Britain officially asked its regulator, the MHRA, last week to assess the latest data on the Pfizer vaccine. In fact, the UK has ordered 40 million doses of the vaccine. The British government also hopes that from the 10 million doses that will be present at the end of the year it can protect five million people who are vulnerable to contracting COVID-19.